Startups
Archivel Farma is a R&D biotech company that develops immunotherapeutic agents to respond to unmet medical needs, specifically it has been committed in fighting tuberculosis (TB). Archivel Farma is developing RUTI®, a therapeutic vaccine for the treatment of active TB.
Overview
Location
Spain, Catalonia, Barcelona
Employees
11-50
Founded date
2005
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 25, 2011 | Archivel Farma finaliza la Fase II del ensayo clínico de la vacuna RUTI | 25/05/2011 Nota de prensa ARCHIVEL FARMA FINALIZA LA FASE II DEL ENSAYO CLÍNICO DE LA VACUNA RUTI. El 21 de junio del 2010, Archivel Farma empezaba el ensayo clínico de fase II de la vacuna RUTI©, en individuos con tuberculosis latente (... |
| Apr 3, 2009 | Archivel Farma prepara una nueva ronda entre 7 y 10 millones a la que acudirá bcnHighgrowth | 03/04/2009 ARCHIVEL FARMA PREPARA UNA NUEVA RONDA DE FINANCIACIÓN ENTRE 7 Y 10 MILLONES A LA QUE ACUDIRÁ BCNHIGHGROWTH. Según informa el diario Expansión , la compañía biotecnológica Archivel Farma acaba de iniciar una ronda de financiaci... |
Reviews 0
FAQ about Archivel Farma S.L.
When was Archivel Farma S.L. founded?
Archivel Farma S.L. was founded in 2005.
What has the press written about Archivel Farma S.L.?
Parsers VC has collected 3 articles mentioning Archivel Farma S.L., among them “Archivel Farma finaliza la Fase II del ensayo clínico de la vacuna RUTI” (May 25, 2011) and “Archivel Farma prepara una nueva ronda entre 7 y 10 millones a la que acudirá bcnHighgrowth” (Apr 3, 2009).
Is Archivel Farma S.L. still active?
Yes, Archivel Farma S.L. is active; its latest activity on Parsers VC dates from Jul 15, 2020.